Fate Therapeutics stock forecast 2022 - 2025 - 2030 with analysis. Ad Were all about helping you get more from your money.
Snap Shock Sends Nasdaq Plummeting In 2022 Nasdaq Nasdaq 100 Snaps
Close price at the end of the last trading day Wednesday 3rd Aug 2022 of the FATE stock was 3281.
. This is 712 more than the trading day before Tuesday 2nd Aug. According to latest technical analysis Fate. The Score for FATE is 67 which is 34 above its historic median score of 50 and infers lower risk than normal.
Positive dynamics for Fate Therapeutics shares will prevail with possible. Discover the Power of thinkorswim Today. The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 8200 with a high estimate of 13500 and a low estimate of 2800.
Is FATE a good long term stock. The average price target is 7475 with a high. FATE analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.
New report out now. When should I take profit in. Find out which stock could jump next.
Based on 11 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. Stock forecast for tomorrow and next 5 days. In 2024 FATE is forecast to generate 11712894538 in revenue with the lowest revenue forecast at 6054778466 and the highest revenue forecast at 21319275024.
According to 27 stock analysts the average 12-month stock price forecast for FATE stock is 8175 which predicts an increase of 14916. FATE stock forecast Our latest prediction for Fate Therapeutics Incs stock price was made on the Aug. Access the Nasdaqs Largest 100 non-financial companies in a Single Investment.
The lowest target is 2828. Taking a look at stock we notice that its last check on previous day was 3242 and 5Y monthly beta was reading 158 with its price kept floating in the range of 3197 and. 19 2021 when the stock price was at 8563.
The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information. Lets get started today. Fate Therapeutics stock forecasts are adjusted once a day.
Ad See how Invesco QQQ ETF can fit into your portfolio. In the next year analysts believe that Fair Value will reach 3133. Fate Therapeutics stock stood at 267999992370606 on 2022-06-24.
Get the latest FATE stock forecast powered by the most important price indicators. The minimum target price for Fate Therapeutics analysts is. Trade stocks bonds options ETFs and mutual funds all in one easy-to-manage account.
Volatile ride for Fate Therapeutics stock price on Monday moving between 3371 and 3713 Updated on Aug 08 2022 Buy or Hold candidate since 2022-07-27 Gain 292. The average Fate Therapeutics stock forecast from last 6 month is 5883 and this show a -1751 decrease in average from the prior price target of the each prediction. If yes then on this page you will find useful information about the dynamics of the FATE stock price in 2022-2027.
Ad These 5 fascinating stocks are the most important investments for the next 90 days. Fate Therapeutics FATE Analyst Forecast FATE Price Volume Earnings and Dividend Date Last Price 3414 Previous Close 3414 Change 000 Open 3399 Volume 2013400 Avg. Forecast target price for 07-30-2022.
Fate Therapeutics Stock Forecast 07-30-2022. Analyst Price Target on FATE. Get an edge in the market with our Fate Therapeutics Inc.
Fate Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. Tiny company is a sneaky EV play that no ones talking about but should be. Find the latest Fate Therapeutics Inc.
In the short term 2weeks FATEs. In the past three years Fate Therapeuticss Price has grown rising from 000 to 000 a growth of 10000. Ad This analysts last stock recommendations soared hundreds of percent very quickly.
The current Fate Therapeutics FATE share price is 3342.
Honeycomb Paper Pallet Big Stock Clearance All Have A Best Competitive Price If You Are Interested In Please F Honeycomb Paper Uses Of Paper Honeycomb Shape
Executive Summary Hefty Trade Gap In May Did Not Severely Undermine The Bop Competitive Php Boost Unable To Offset Lackluster Export D Swellings Trading Gap
Executive Summary Hefty Trade Gap In May Did Not Severely Undermine The Bop Competitive Php Boost Unable To Offset Lackluster Export D Swellings Trading Gap
